9 recruiting, 7 active not recruiting, 6 completed, 5 unknown. 12 Phase 2, 6 Phase 1, 6 Phase 3, 4 Phase 4, 3 Early Phase 1.
Follow dexamethasone oral: new trials by email Literature Review of dexamethasone oral trials Research Report on dexamethasone oral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dosing of Steroids for Acute Asthma Given in the Emergency Department - a Pilot Randomised Feasibility Trial of Dexamethasone in Children dexamethasone oral - Acute Asthma, Dexamethasone | Phase 4 | Recruiting | Sheffield Children's NHS Foundation Trust | 104 | 2026-02-23 | 2026-04-23 |
| Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM Dexamethasone oral - Breast Neoplasms, Lung Neoplasms | Phase 2 | Recruiting | Brown University | 60 | 2025-10-22 | 2025-10-24 |
| Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease N-Acetyl cysteine, Dexamethasone Oral, N-Acetyl cysteine Placebo - Lung Cancer, Interstitial Lung Disease | Phase 2 | Recruiting | David Palma | 98 | 2025-01-07 | 2026-08-26 |
| Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate [18F]CETO tracer, Dexamethasone oral, Adrenal vein sampling - Primary Aldosteronism | Phase 1 / Phase 2 | Recruiting | University Medical Center Groningen | 12 | 2024-11-06 | 2025-01-27 |
| Dexamethasone/Pancreatic Clamp P&F Insulin human, Octreotide Acetate, Glucagon - Insulin Resistance, Prediabetic State | Phase 1 | Withdrawn | Columbia University | 2024-07-01 | 2024-07-10 | |
| TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children Dexamethasone Oral, Placebo - Rheumatic Fever, Sydenham Chorea | Phase 3 | Recruiting | Starship Child Health, Te Toka Tumai Auckland | 80 | 2024-06-17 | 2025-06-24 |
| NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens Netupitant / Palonosetron Oral Capsule [Akynzeo], Olanzapine, Dexamethasone Oral - Chemotherapy-induced Nausea and Vomiting, Highly Emetogenic Chemotherapy | Phase 3 | Completed | Fudan University | 644 | 2024-05-01 | 2026-04-09 |
| The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP Hydroxychloroquine Oral Tablet, Dexamethasone oral - Immune Thrombocytopenia With Positive ANA Antibodies | Not applicable | Recruiting | Yunfeng Cheng | 129 | 2024-04-24 | 2024-06-28 |
| Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma Linperlisib, Camrelizumab, Pegaspargase - Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, T-lymphoblastic Lymphoma | Phase 1 / Phase 2 | Recruiting | Beijing Tongren Hospital | 43 | 2024-04-14 | 2024-04-19 |
| Oral Dexamethasone for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy Dexamethasone Oral, Dexamethasone - Postoperative Nausea and Vomiting | Phase 3 | Unknown | Mansoura University | 814 | 2024-03-04 | 2024-03-12 |
| The Bronchiolitis in Hospitalized Infants Study Dexamethasone Oral - Bronchiolitis | Early Phase 1 | Withdrawn | IDeA States Pediatric Clinical Trials Network | 2023-10-09 | 2023-09-14 | |
| Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? Dexamethasone Oral, Placebo - Migraine | Early Phase 1 | Recruiting | Texas Tech University Health Sciences Center, El Paso | 84 | 2023-09-15 | 2026-05-06 |
| Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14) Venetoclax, Dexamethasone Oral - Light Chain (AL) Amyloidosis, CCND1 Translocation | Phase 2 | Active not recruiting | Peking Union Medical College Hospital | 36 | 2023-09-07 | 2025-01-22 |
| Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain. Ibuprofen 400 mg, Dexamethasone Oral, Educational Intervention - Radiculopathy, Lumbosacral Region, Back Pain With Radiation | Phase 4 | Recruiting | Montefiore Medical Center | 132 | 2023-07-05 | 2026-04-13 |
| Oral Dexamethasone for the Management of Symptomatic Irreversible Pulpitis Without Performing Pulpotomy Dexamethasone Oral - Irreversible Pulpitis | Phase 1 | Unknown | May Samaha | 80 | 2023-02-15 | 2023-03-09 |
| A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma Selinexor, Elotuzumab, Pomalidomide - Multiple Myeloma | Phase 3 | Active not recruiting | European Myeloma Network B.V. | 117 | 2022-04-19 | 2025-12-04 |
| Dexamethasone to Target Stress and Immune System Mechanisms Underlying Alcohol Craving Dexamethasone Oral, Placebo - Alcohol Use Disorder | Early Phase 1 | Completed | Stony Brook University | 27 | 2022-03-11 | 2026-10-02 |
| A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." Ixazomib, Iberdomide, Dexamethasone Oral - Multiple Myeloma at First Relapse | Phase 2 | Active not recruiting | Nantes University Hospital | 75 | 2021-12-14 | 2026-06-15 |
| Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM Isatuximab-Irfc 20 MG/ML [Sarclisa], Lenalidomide, Dexamethasone Oral - Newly Diagnosed Multiple Myeloma | Phase 2 | Active not recruiting | Arbeitsgemeinschaft medikamentoese Tumortherapie | 198 | 2021-10-20 | 2025-04-10 |
| Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma Selinexor, Dexamethasone Oral, Daratumumab - Multiple Myeloma, Myeloma Multiple | Phase 2 | Active not recruiting | US Oncology Research | 73 | 2021-09-10 | 2025-01-16 |
Showing 20 of 31. Sign in to see all of them.
Multiple Myeloma (7) · Neoplasms, Plasma Cell (3) · Bronchiolitis (2) · Lung Neoplasms (2) · Acute Pain (1) · Alcoholism (1) · Amyloidosis (1) · Anaphylaxis (1) · Back Pain (1) · Brain Edema (1) · Brain Injuries, Traumatic (1) · Breast Neoplasms (1) · Bronchiolitis, Viral (1) · Carcinoma, Non-Small-Cell Lung (1) · Chorea (1)
Hamad Medical Corporation (2) · AbbVie (prior sponsor, Abbott) (1) · Aetion, Inc. (1) · Allison Williams (1) · Arbeitsgemeinschaft medikamentoese Tumortherapie (1) · Beijing Tongren Hospital (1) · Brown University (1) · C4 Therapeutics, Inc. (1) · Columbia University (1) · David Palma (1) · European Myeloma Network B.V. (1) · Fudan University (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · IDeA States Pediatric Clinical Trials Network (1) · Ida Bruun Kristensen (1)
United States (12) · China (4) · France (2) · Greece (2) · Qatar (2) · Spain (2) · Australia (1) · Austria (1) · Canada (1) · Denmark (1) · Egypt (1) · Estonia (1) · Germany (1) · Hong Kong (1) · Lebanon (1)
Allison E Williams, MD (1) · Ashley Deschamp, MD,MS (1) · Cyrille Touzeau (1) · David Palma, MD (1) · Diluma Kariyawasam, MPH (1) · Dr. M.N. Kerstens (1) · Eddie Irizarry, MD (1) · Hannah F Jones, MBChB PhD (1) · Hanne Norseth, MD (1) · Heinz Ludwig (1) · Helen C Fox, PhD (1) · Houda Bahig, MD (1) · Ida B Kristensen, MB (1) · Jian Zhang, MD,PhD (1)
PMID 24254965, PMID 26686406, PMID 28416506, PMID 33496659, PMID 33546038, PMID 33859526, PMID 35288899, PMID 36074157, PMID 40760578, PMID 40983035, PMID 42241642
2023 (2), 2019 (1), P30DK063608 (1)